Toth Financial Advisory Corp Sells 2,591 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Toth Financial Advisory Corp reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 39,271 shares of the financial services provider’s stock after selling 2,591 shares during the quarter. Toth Financial Advisory Corp owned approximately 0.08% of iShares Biotechnology ETF worth $5,192,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Grimes & Company Inc. bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $3,462,000. Geneos Wealth Management Inc. lifted its position in iShares Biotechnology ETF by 52.4% during the fourth quarter. Geneos Wealth Management Inc. now owns 873 shares of the financial services provider’s stock valued at $115,000 after purchasing an additional 300 shares during the period. Dynamic Advisor Solutions LLC lifted its holdings in shares of iShares Biotechnology ETF by 41.0% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 5,507 shares of the financial services provider’s stock valued at $728,000 after buying an additional 1,600 shares during the period. Brighton Jones LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter worth about $201,000. Finally, Madrona Financial Services LLC grew its stake in shares of iShares Biotechnology ETF by 786.5% during the 4th quarter. Madrona Financial Services LLC now owns 32,075 shares of the financial services provider’s stock valued at $4,241,000 after purchasing an additional 28,457 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $137.30 on Friday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm has a 50 day moving average of $136.04 and a 200 day moving average of $141.78.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.